creon 24000- pancrelipase capsule, delayed release pellets creon 3000- pancrelipase capsule, delayed release pellets creon 600
abbott laboratories gmbh - pancrelipase lipase (unii: 8myc33932o) (pancrelipase lipase - unii:8myc33932o), pancrelipase protease (unii: 3560d81v50) (pancrelipase protease - unii:3560d81v50), pancrelipase amylase (unii: yoj58o116e) (pancrelipase amylase - unii:yoj58o116e) - pancrelipase, 3000 delayed-release capsules (bulk) pancrelipase, 6000 delayed-release capsules (bulk) pancrelipase, 12000 delayed-release capsules (bulk) pancrelipase, 24000 delayed-release capsules (bulk) pancrelipase, 36000 delayed-release capsules (bulk)
lipantil supra 145 milligram coated tablets
abbott healthcare products ltd - fenofibrate - coated tablets - 145 milligram
lipantil micro 67 milligram capsules hard
bgp products ltd - fenofibrate - capsules hard - 67 milligram - fibrates - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil micro 200mg capsules, hard.
bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil supra 145 milligram film coated tablet
bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. mixed hyperlipidaemia when a statin is contraindicated or not tolerated. mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil micro 200 milligram capsules hard
bgp products ltd - fenofibrate - capsules hard - 200 milligram - fibrates
lipantil supra 215 milligram film coated tablet
bgp products ltd - fenofibrate - film coated tablet - 215 milligram - fibrates
lipantil micro 67 mg hard capsules.
mylan ire healthcare limited - fenofibrate - capsule, hard - 67 milligram(s) - fibrates; fenofibrate
lipantil supra 145mg film-coated tablets
mylan ire healthcare limited - fenofibrate - film-coated tablet - 145 milligram(s) - fibrates; fenofibrate
lipantil supra 215 mg, film-coated tablet
mylan ire healthcare limited - fenofibrate - film-coated tablet - 215 milligram(s) - fibrates; fenofibrate